bufalin has been researched along with Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Li, Y; Tu, H; Wang, S; Xie, Y; Yang, Q; Yuan, J; Zhang, Y; Zhou, X | 1 |
1 other study(ies) available for bufalin and Melanoma
| Article | Year |
|---|---|
Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Biomarkers; Bufanolides; CD40 Antigens; Cell Survival; Female; Liposomes; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Spleen; Tissue Distribution | 2014 |